Illuminating the role of chloride channel regulator CLCA4 in TMEM16 Family potentiation and disease
Illuminating the role of chloride channel regulator CLCA4 in TMEM16 Family potentiation and disease
批准号:
10217542
负责人:
THOMAS John BRETT
金额:
$15.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-05-15 至 2023-05-14
关键词:
Airway DiseaseAnionsAntibodiesAsthmaBindingBiochemicalBiologicalBiological ProcessBrainCalciumCell Culture TechniquesCellsChemosensitizationChloride ChannelsChloridesChronic Obstructive Airway DiseaseCleaved cellCrohn&aposs diseaseCystic FibrosisDataDiarrheaDigestive System DisordersDiseaseDrug TargetingElectrophysiology (science)Enzyme-Linked Immunosorbent AssayFamilyFamily memberFutureGastrointestinal DiseasesGastrointestinal tract structureGeneticGoalsHealthHumanInflammatoryIntestinesKnowledgeLiteratureLungLung diseasesMalignant NeoplasmsMetalloproteasesMolecularMonoclonal AntibodiesMucous MembranePatternPilot ProjectsPlayProtein FamilyProteinsReagentRegulationResearchRoleSamplingStainsStructureSurfaceSystemTissuesUlcerative Colitisbaseexperimental studyknowledge basemRNA Expressionmembernoveltargeted treatmenttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT:
The calcium-activated chloride channel regulator CLCA4 has been associated with and suggested as a
drug target for inflammatory diseases of the airway and gastrointestinal tract including asthma, COPD, cystic
fibrosis, infectious diarrhea, Crohn's disease, ulcerative colitis, and some cancers. However, a detailed
understanding of its biological functions has lagged far behind its association with these diseases, largely due
to complete lack of biochemical knowledge and quality antibody reagents. We recently made groundbreaking
advances investigating a related family member, CLCA1, by showing that it is a self-cleaving metalloprotease
that binds to and potentiates the calcium activated chloride channel TMEM16A. In our preliminary data we
show that CLCA4 acts in a similar manner on another distinct TMEM16 family member, TMEM16B. Therefore,
we are uniquely poised to generate significant advances in our understanding of CLCA4 function in health and
disease. This pilot project will develop the knowledge base and tools required to facilitate this. In Aim 1, we will
investigate the mechanism of regulation of CLCA4 activity and comprehensively validate that TMEM16B is the
sole TMEM16 family member modulated by CLCA4. In Aim 2, we will develop a novel panel of monoclonal
antibody reagents specific for the mature, cleaved forms of CLCA4 (N-CLCA4 and C-CLCA4) that can be used
in several experimental formats, and carry out initial analysis of healthy and diseased airway and intestinal
tissue and biological samples with them. The long-term goal of this project (beyond this pilot R03) is to develop
a comprehensive mechanistic understanding of CLCA4 function in health and disease, which we believe is
sorely underappreciated. Successful completion of this pilot will provide the knowledge and tools to investigate
the functional roles of CLCA4 in specific diseases and to develop targeted therapeutics in subsequent projects.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/cpz1.512
发表时间:
2022-08
期刊:
Current protocols
影响因子:
--
作者:
[]
通讯作者:
Development of tools and knowledge to facilitate the investigation of chloride channel regulator CLCA2 in rare human diseasses
-
批准号:10728179
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2023
-
负责人:THOMAS John BRETT
-
依托单位:
STRUCTURAL REGULATION OF CLCA1 ACTIVITY
-
批准号:8563052
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2013
-
负责人:THOMAS John BRETT
-
依托单位:
STRUCTURAL REGULATION OF CLCA1 ACTIVITY
-
批准号:9256526
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2013
-
负责人:THOMAS John BRETT
-
依托单位:
STRUCTURAL REGULATION OF CLCA1 ACTIVITY
-
批准号:9054910
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2013
-
负责人:THOMAS John BRETT
-
依托单位:
STRUCTURAL REGULATION OF CLCA1 ACTIVITY
-
批准号:8706230
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2013
-
负责人:THOMAS John BRETT
-
依托单位:
STRUCTURAL REGULATION OF CLCA1 ACTIVITY
-
批准号:9387711
-
项目类别:
-
资助金额:$1.59万
-
财政年份:2013
-
负责人:THOMAS John BRETT
-
依托单位:
海外基金